Improved protein kinase C affinity through final step diversification of a simplified salicylate-derived bryostatin analog scaffold

Organic Letters

Volumn 16, Issue 19, 2014, Pages 5140-5143

  Wender, Paul A ^a   Staveness, Daryl ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRYOSTATIN; BRYOSTATIN 1; PROTEIN KINASE C; SALICYLIC ACID DERIVATIVE;

CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; HUMAN; SYNTHESIS;

BRYOSTATINS; HUMANS; MOLECULAR STRUCTURE; PROTEIN KINASE C; SALICYLATES;

EID: 84907700495     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol502492b     Document Type: Article

References (36)

1. Pettit, G. R.; Herald, C. L.; Doubek, D. L.; Herald, D. L.; Arnold, E.; Clardy, J. J. Am. Chem. Soc. 1982, 104, 6846-6848
2. For current clinical information, see: http://clinicaltrials.gov.
3. Kortmansky, J.; Schartz, G. K. Cancer Invest. 2003, 21, 924-936
4. Gennas, G. B.; Talman, V.; Yli-Kauhaluoma, J.; Tuominen, R.; Ekokoski, E. Curr. Top. Med. Chem. 2011, 11, 1370-1392
5. Shaha, S.; Tomic, J.; Shi, Y.; Pham, T.; Mero, P.; White, D.; He, L.; Baryza, J.; Wender, P.; Booth, J.; Spaner, D. Clin. Exp. Immunol. 2009, 158, 186-198
6. Sun, M. K.; Hongpaisan, J.; Nelson, T. J.; Alkon, D. L. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 13620-13625
7. Tan, Z.; Turner, R.; Leon, R.; Li, X.; Hongpaisan, J.; Zheng, W.; Logsdon, A.; Naser, Z.; Alkon, D.; Rosen, C.; Huber, J. Stroke 2013, 44, 3490-3497
8. Hongpaisan, J.; Alkon, D. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 19571-19576
9. Kim, H.; Han, S.; Quan, H.; Jung, Y.; An, J.; Kang, P.; Park, J.; Yoon, B.; Seol, G.; Min, S. Neuroscience 2012, 226, 348-355
10. Trial is still recruiting as of Aug. 20, 2014, (NCT02221947).
11. Wender, P.; Kee, J. M.; Warrington, J. Science 2008, 320, 649-652
12. Beans, E.; Fournogerakis, D.; Gauntlett, C.; Heumann, L.; Kramer, R.; Marsden, M.; Murray, D.; Chun, T.; Zack, J.; Wender, P. Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 11698-11703
13. Mehla, R.; Bivalkar-Mehla, S.; Zhang, R.; Handy, I.; Albrecht, H.; Giri, S.; Nagarkatti, P.; Nagarkatti, M.; Chauhan, A. PLoS One 2010, 5, e11160
14. For a commentary on the long-term physical and social effects of chronic HAART treatment, see: Leland, J. People Think It's Over. The New York Times, June 2nd, 2013; p MB1.
15. Chan, C. N.; Dietrich, I.; Hosie, M.; Willet, B. J. Gen. Virol. 2013, 94, 917-932
16. Bullen, C. K.; Laird, G.; Durand, C.; Siliciano, J.; Siliciano, R. Nat. Med. 2014, 20, 425-430
17. Archin, N.; Margolis, D. Curr. Opin. Infect. Dis. 2014, 27, 29-35
18. Wender, P. A.; Nakagawa, Y.; Near, K. E.; Staveness, D. Org. Lett. 2014, DOI: 10.1021/ol502491f.
19. Wender, P.; Verma, V.; Paxton, T.; Pillow, T. Acc. Chem. Res. 2008, 41, 40-49
20. Wender, P.; Miller, B. Nature 2009, 460, 197-201
21. Newman, D.; Cragg, G. J. Nat. Prod. 2012, 75, 311-335
22. Wender, P.; Donnelly, A.; Loy, B.; Near, K.; Staveness, D. In Natural Products in Medicinal Chemistry; Hanessian, S., Ed.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 2014; pp 475-544.
23. These efforts were highlighted in a recent review: Cragg, G.; Grothaus, P.; Newman, D. J. Nat. Prod. 2014, 77, 703-723
24. Several C1-domain containing proteins are possible targets for bryostatin; see: Kazanietz, M. G. Mol. Pharmacol. 2002, 61, 759-767
25. Steinberg, S. Physiol. Rev. 2008, 88, 1341-1378
26. Newton, A. Am. J. Physiol. Endocrinol. Metab. 2010, 298, E395-E402
27. Mochly-Rosen, D.; Das, K.; Grimes, K. Nat. Rev. Drug Discovery 2012, 11, 937-954
28. Wu-Zhang, A.; Newton, A. Biochem. J. 2013, 452, 195-209
29. Wender, P.; Baryza, J.; Brenner, S.; DeChristopher, B.; Loy, B.; Schrier, A.; Verma, V. Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 6721-6726
30. DeChristopher, B.; Loy, B.; Marsden, M.; Schrier, A.; Zack, J.; Wender, P. Nat. Chem. 2012, 4, 705-710
31. Wender, P. A.; Nakagawa, Y.; Near, K. E.; Staveness, D. Org. Lett. 2014, DOI: 10.1021/ol502491f.
32. Wender, P. A.; Baryza, J. L.; Bennett, C. E.; Bi, C.; Brenner, S. E.; Clarke, M. O.; Horan, J. C.; Kan, C.; Lacote, E.; Lippa, B.; Nell, P. G.; Turner, T. M. J. Am. Chem. Soc. 2002, 124, 13648-13649
33. Wender, P.; Reuber, J. Tetrahedron 2011, 67, 9998-10005
34. Adapted from methods in: Luning, U.; Abbass, M.; Fahrenkrug, F. Eur. J. Org. Chem. 2002, 3294-3303
35. Rahman, G.; Shanker, S.; Lewin, N.; Kedei, N.; Hill, C.; Prasad, V.; Blumberg, P.; Das, J. Biochem. J. 2013, 451, 33-44
36. Newton, A. Am. J. Physiol. Endocrinol. Metab. 2010, 298, E395-E402